- US12357607utility2025Compositions and Methods for Intravenous Administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone0 cites
- US12357608utility2025Methods and Compositions Utilizing Rrx-001 Combination Therapy for Radioprotection0 cites
- US12295976utility2025Personalized Cancer Vaccines0 cites
- US12291726utility2025A549 Host Cells Comprising a Recombinant Oncolytic Adenovirus with Modified E1A Cancer-specific Promoter0 cites
- US12280123utility2025Recombinant Adenoviruses Carrying Transgenes0 cites
- US12109348utility2024Medication Infusion Devices, Systems, and Methods0 cites
- US12054530utility2024Immunomodulatory Fusion Proteins0 cites
- US12048793utility2024Medication Infusion Devices, Systems, and Methods0 cites
- US12036247utility2024Multiple Transgene Recombinant Adenovirus0 cites
- US11999973utility2024Method for Producing Recombinant Oncolytic Adenovirus with Modified E1a Cancer-specific Promoter0 cites
- US11834492utility2023Human IL-10 Receptor Alpha Fusion Proteins0 cites
- US11744859utility2023Compositions and Methods for Parenteral Administration of Therapeutic Agents0 cites
- US11701351utility2023Treatment of Gliomas Using Organonitro Compound Combination Therapy0 cites
- US11576895utility2023Compositions and Methods for Intravenous Administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone0 cites